Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.050
-0.120 (-5.53%)
At close: Jun 27, 2025, 4:00 PM
2.150
+0.100 (4.88%)
After-hours: Jun 27, 2025, 5:05 PM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $39.95 million as of June 27, 2025. Its market cap has decreased by -44.99% in one year.
Market Cap
39.95M
Enterprise Value
17.71M
1-Year Change
-44.99%
Ranking
Category
Stock Price
$2.05
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $39.95M, a decrease of -36.09%. That is a compound annual growth rate of -7.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 42.29M | -39.07% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.30B |
| Johnson & Johnson | 364.78B |
| AbbVie | 329.17B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.58B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.17B |
| AstraZeneca | 216.45B |